Blood to brain distribution of neuroleptics

Knowledge of the tissue distribution of drugs is important in interpreting other more commonly measured pharmacokinetic parameters, such as levels of drug in blood. For the neuroleptics, studies of blood to brain distribution are few and, due to technical differences between studies, the results are neither consistent within drugs nor comparable between drugs. We estimated the plasma to brain distribution of several common neuroleptics in rats using a single technique, the radioreceptor assay for neuroleptics. At doses that led to plasma levels similar to those achieved in clinical use, brain to plasma ratios ranged from 34 and 22 for fluphenazine and haloperidol, respectively, to 2.2 and 0.97 for thioridazine and mesoridazine, respectively. In general, clinical milligram potency and the favorability of distribution to brain ranked in the same order. These results may explain why such low levels of the high potency neuroleptics and such high levels of the low potency neuroleptics, greater than can be explained by relative differences between the same drugs in potency in vitro, are observed in blood both by radioreceptor and chemical assay techniques.

[1]  S. Curry,et al.  The Physiological Disposition of Chlorpromazine in the Rat and Dog , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  B. Cohen,et al.  Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat. , 1980, Life sciences.

[3]  B. Cohen,et al.  Radioreceptor assay of haloperidol tissue levels in the rat , 1980, Neuropharmacology.

[4]  S. Snyder,et al.  Antischizophrenic drugs: differential plasma protein binding and therapeutic activity. , 1979, Life sciences.

[5]  P. Seeman,et al.  Anti-schizophrenic drugs--membrane receptor sites of action. , 1977, Biochemical pharmacology.

[6]  B. Cohen,et al.  Fluphenazine blood levels and clinical response. , 1982, Biological psychiatry.

[7]  S. Snyder,et al.  Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations , 1979, Psychiatry Research.

[8]  B. Cohen,et al.  Clinical use of the radioreceptor assay for neuroleptics , 1980, Psychiatry Research.

[9]  Malcolm Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[10]  B. Cohen The Clinical Utility of Plasma Neuroleptic Levels , 1984 .

[11]  S. Snyder,et al.  A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood , 1977, Nature.

[12]  R. Mailman,et al.  Serum effects confound the neuroleptic radioreceptor assay. , 1984, Life sciences.